✦ LIBER ✦

330 INVITED The Development of Vemurafenib for BRAF-mutated, Metastatic Melanoma

✍ Scribed by F. Borellini

Book ID: 117661041
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 38 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(11)70545-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vemurafenib (PLX4032): An Orally Availab

Vemurafenib (PLX4032): An Orally Available Inhibitor of Mutated BRAF for the Treatment of Metastatic Melanoma

✍ Heakal, Y.; Kester, M.; Savage, S. 📂 Article 📅 2011 🏛 Harvey Whitney Books Company 🌐 English ⚖ 164 KB

Vemurafenib and BRAF Inhibition: A New C

Vemurafenib and BRAF Inhibition: A New Class of Treatment for Metastatic Melanoma

✍ Luke, J. J.; Hodi, F. S. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 568 KB

NICE guidance on vemurafenib for treatin

NICE guidance on vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma

✍ Kumar Perampaladas; Nicola Hay; Fiona Rinaldi; Janet Robertson; Jane Adam 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 50 KB

98 Treating Metastatic Melanoma With the

98 Treating Metastatic Melanoma With the BRAF Inhibitor Vemurafenib and Mechanisms of Resistance

✍ P. Chapman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

PCN87 Cost Effectiveness Evaluation of V

PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma

✍ M. Alva; J.G. Gay; R. Sanchez Kobashi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Vemurafenib for the Treatment of Locally

Vemurafenib for the Treatment of Locally Advanced or Metastatic BRAF V600 Mutation-Positive Malignant Melanoma: A NICE Single Technology Appraisal

✍ Beale, Sophie; Dickson, Rumona; Bagust, Adrian; Blundell, Michaela; Dundar, Yena 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 282 KB